OR WAIT 15 SECS
January 18, 2021
Medicinal mushrooms saw skyrocketing growth in 2020 during the COVID-19 pandemic. Is this the first step in their mainstream journey?
January 15, 2021
Researchers with the Fatty Acid Research Institute, in collaboration with Cedars-Sinai Medical Center in Los Angeles, CA, recently posted the results of a pilot study which found a potential link between low Omega-3 Index levels and mortality from COVID-19 infection.
January 11, 2021
A recent study called the Personalised Responses to Dietary Composition Trial (PREDICT 1) study, is among the largest and most detailed on the microbiome after performing deep metagenomic sequencing of 1,203 gut microbiomes from 1,098 individuals.
January 08, 2021
A recent review summarized the current research on marine polysaccharide fucoidan and its potential to limit lung damage from viral respiratory infections.
Low vitamin K2 status may be associated with increased mortality from COVID-19 illness, according to a recent preprint that is awaiting peer review.
January 06, 2021
As part of their collaboration, Aker has entered into an exclusive licensing agreement with University of Illinois Chicago for the current intellectual property resulting from the University's work on LPC-bound EPA and DHA.
Brightseed, a bioscience company and creator of the artificial intelligence platform called Forager, has announced preclinical data from its first major discovery targeting liver and metabolic health.
January 04, 2021
A recently-published study found that a branded eye health formula from Sabinsa Corp. called Macumax supported symptoms of age-related macular degeneration.
December 18, 2020
Epax was awarded a $900,000 grant from the Norwegian Research Council to research the potential of new fatty acids for human health over the next four years.
December 17, 2020
A recently published study found that ErgoActive from Blue California helped preserve telomere length and reduced the rate of telomere shortening under oxidative stress.